SCHEMBL556965

SCHEMBL556965

O=c1sc2nc3ccccc3nc2s1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.59
MAPT P10636 8/20 0.48
ALDH1A1 P00352 8/20 0.40
HSD17B10 Q99714 5/20 0.40
KDM4E B2RXH2 5/20 0.40
HPGD P15428 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
GAA P10253 2/20 0.40
AHR P35869 1/20 0.40
NQO2 P16083 2/20 0.39
PSMB8 P28062 1/20 0.36
PSMB5 P28074 1/20 0.36
POLB P06746 2/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL472804 0.84 TDP1 (0.58) TDP1MAPTALDH1A1KDM4EHPGD
Chinomethionat SCHEMBL1069085 0.77 TDP1 (0.77) TDP1MAPTALDH1A1KDM4EHPGD
SCHEMBL10923431 0.76 TDP1 (0.50) TDP1MAPTALDH1A1HSD17B10RAB9A
SCHEMBL30061114 0.75 MAPT (0.48) TDP1MAPTALDH1A1HSD17B10KDM4E
SCHEMBL54635 0.75 MAPT (0.48) TDP1MAPTALDH1A1HSD17B10KDM4E
Chinomethionat SCHEMBL29358969 0.74 TDP1 (1.00) TDP1MAPTALDH1A1KDM4ESMN1; SMN2
Phenazine SCHEMBL9049 0.67 MAPT (1.00) TDP1MAPTALDH1A1HSD17B10KDM4E
Phenazine SCHEMBL29356959 0.67 MAPT (1.00) TDP1MAPTALDH1A1HSD17B10KDM4E
Phenazine SCHEMBL27643128 0.67 MAPT (1.00) TDP1MAPTALDH1A1HSD17B10KDM4E
SCHEMBL11807766 0.67 MAPT (0.39) TDP1MAPTALDH1A1HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0085907-B1 QUINOXALINE COMPOUNDS OR A COMBINATION THEREOF WITH O-DICHLOROBENZENE FOR USE AGAINST ANIMAL COCCIDIOSIS Eisai Co., Ltd. (JP) 1986-08-20 EP claimed
EP-0085907-A1 Quinoxaline compounds or a combination thereof with o-dichlorobenzene for use against animal coccidiosis Eisai Co., Ltd. (JP) 1983-08-17 EP claimed
US-8530673-B2 Tetrathiafulvalene derivative, and organic film and organic transistor using the same RICOH COMPANY, LTD. (JP) 2013-09-10 US disclosed
US-20120035364-A1 TETRATHIAFULVALENE DERIVATIVE, AND ORGANIC FILM AND ORGANIC TRANSISTOR USING THE SAME RICOH COMPANY, LTD. (JP) 2012-02-09 US disclosed
EP-0085907-B1 QUINOXALINE COMPOUNDS OR A COMBINATION THEREOF WITH O-DICHLOROBENZENE FOR USE AGAINST ANIMAL COCCIDIOSIS Eisai Co., Ltd. (JP) 1986-08-20 EP disclosed
US-4434166-A 1,3-DITHIOLO(4,5-B)QUINOXALINE DERIVATIVES EISAI CO., LTD. (JP) 1984-02-28 US disclosed
EP-0085907-A1 Quinoxaline compounds or a combination thereof with o-dichlorobenzene for use against animal coccidiosis Eisai Co., Ltd. (JP) 1983-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035364-A1 TETRATHIAFULVALENE DERIVATIVE, AND ORGANIC FILM AND ORGANIC TRANSISTOR USING THE SAME TCOF1, F12, F5 TDP1 711/4885MAPT 1984/4885ALDH1A1 2811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.